Fabrice Ruiz

875 total citations
33 papers, 548 citations indexed

About

Fabrice Ruiz is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Fabrice Ruiz has authored 33 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pediatrics, Perinatology and Child Health, 8 papers in Geriatrics and Gerontology and 6 papers in Epidemiology. Recurrent topics in Fabrice Ruiz's work include Pharmaceutical studies and practices (18 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Antibiotic Use and Resistance (5 papers). Fabrice Ruiz is often cited by papers focused on Pharmaceutical studies and practices (18 papers), Pharmaceutical Practices and Patient Outcomes (7 papers) and Antibiotic Use and Resistance (5 papers). Fabrice Ruiz collaborates with scholars based in France, United Kingdom and Germany. Fabrice Ruiz's co-authors include Anne‐Marie Pensé‐Lhéritier, Jennifer S. Smith, Philippe Halfon, Michael G. Hudgens, Laurent Zerat, Karí Syrjänen, Joseph Monsonégo, Améziane Aoussat, Mine Orlu and Marcel Goldberg and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Fabrice Ruiz

31 papers receiving 526 citations

Peers

Countries citing papers authored by Fabrice Ruiz

Since Specialization

Citations

This map shows the geographic impact of Fabrice Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Ruiz more than expected).

Fields of papers citing papers by Fabrice Ruiz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabrice Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Ruiz. The network helps show where Fabrice Ruiz may publish in the future.

Co-authorship network of co-authors of Fabrice Ruiz

This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Ruiz. A scholar is included among the top collaborators of Fabrice Ruiz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Ruiz. Fabrice Ruiz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ceftolozane/Tazobactam for the Treatment of Complicated Infections in Hospital Settings—A French Real-world Study 2024 ·Open Forum Infectious Diseases ·Jean‐François Timsit, Joy Mootien, (unknown), (unknown), (unknown), Bernard Castan, (unknown), (unknown), Fabrice Ruiz, David Boutoille, Raymond Ruimy	3
2	A Guide to Best Practice in Sensory Analysis of Pharmaceutical Formulations 2023 ·Pharmaceutics ·David Clapham, (unknown), Sabine Inghelbrecht, Anne‐Marie Pensé‐Lhéritier, Fabrice Ruiz, (unknown), (unknown), (unknown), (unknown), Catherine Tuleu	4
3	A review of paediatric injectable drug delivery to inform the study of product acceptability – An introduction 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Fabrice Ruiz, Anthony J Nunn, A. Malcolm Gill, David E. Clapham, Nikoletta Fotaki, Smita Salunke, Anne Cram, (unknown)	6
4	Dosage Forms Suitability in Pediatrics: Acceptability of Antibiotics in a German Hospital 2023 ·Antibiotics ·Viviane Klingmann, (unknown), (unknown), (unknown), (unknown), Hans Martin Bosse, Fabrice Ruiz	2
5	Rational and practical considerations to guide a target product profile for patient-centric drug product development with measurable patient outcomes – A proposed roadmap 2022 ·European Journal of Pharmaceutics and Biopharmaceutics ·Sven Stegemann, (unknown), Alessandra Rossi, (unknown), Amrit Paudel, Abina M. Crean, Fabrice Ruiz, Massimo Bresciani, Fang Liu, (unknown), (unknown), (unknown), Anne‐Marie Pensé‐Lhéritier	16
6	POSA11 Ceftolozane-Tazobactam for the Treatment of Complicated Infections in Hospital Settings - Results from a French Real-World Study 2022 ·Value in Health ·Raymond Ruimy, (unknown), (unknown), David Boutoille, (unknown), Bernard Castan, L. Lévy-Bachelot, (unknown), (unknown), (unknown), Fabrice Ruiz, (unknown)	1
7	Adherence and Acceptability of an Oral Antibiotic Used for the Prevention of Pediatric Urinary Tract Infection in Japan 2021 ·Pharmaceutics ·Jumpei Saito, (unknown), Mayumi Yamada, Akimasa Yamatani, Fabrice Ruiz, (unknown)	7
8	Acceptability of Mebendazole Chewable Tablet in Children Aged 2 to 4 Years in Peru 2021 ·Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Fabrice Ruiz	7
9	Proposed Tool to Compare and Assess the Applicability of Taste Assessment Techniques for Pharmaceuticals 2021 ·Journal of Pharmaceutical Sciences ·David Clapham, Joanne Bennett, Anne Cram, (unknown), Sabine Inghelbrecht, Anne‐Marie Pensé‐Lhéritier, Fabrice Ruiz, Smita Salunke, (unknown), (unknown), Jennifer Walsh, Catherine Tuleu	7
10	Exploring Acceptability Drivers of Oral Antibiotics in Children: Findings from an International Observational Study 2021 ·Pharmaceutics ·(unknown), Y. Bensouda, Jumpei Saito, Liv Mathiesen, (unknown), Viviane Klingmann, Matthew Peak, (unknown), Akimasa Yamatani, (unknown), (unknown), (unknown), Louise Bracken, Jennifer C Duncan, Smita Salunke, Siri Wang, Fabrice Ruiz	10
11	Real-world evaluation of ceftolozane/tazobactam therapy and clinical outcomes in France 2021 ·Infectious Diseases Now ·Bernard Castan, (unknown), L. Lévy-Bachelot, (unknown), (unknown), (unknown), (unknown), Joy Mootien, Raymond Ruimy, Fabrice Ruiz, Jean‐François Timsit, David Boutoille	7
12	Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES Study 2021 ·Drug Safety ·(unknown), Claudine Berr, Fabrice Ruiz, Bernard Bégaud, Cédric Lemogne, Marcel Goldberg, Marie Zins, Thibault Mura	5
13	The CONSTANCES Cohort Biobank: An Open Tool for Research in Epidemiology and Prevention of Diseases 2020 ·Frontiers in Public Health ·Joseph Henny, Rachel Nadif, (unknown), Sophie Lemonnier, Anna Ozguler, Fabrice Ruiz, Katy Beaumont, Dominique Brault, Estelle Sandt, Marcel Goldberg, Marie Zins	17
14	PIN91 Ceftolozane-Tazobactam for the Treatment of Pneumonia Due to MULTI-Drug Resistant Ps eudomonas Aeruginosa - Results from a French Real-World Study 2020 ·Value in Health ·L. Lévy-Bachelot, Bernard Castan, (unknown), (unknown), (unknown), (unknown), Raymond Ruimy, Fabrice Ruiz, J-F. Timsit, David Boutoille	0
15	Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians 2019 ·PLoS ONE ·Fabrice Ruiz, (unknown), Amélie Dufaÿ Wojcicki, (unknown), (unknown), Loïc de Pontual, Sylvie Nathanson, (unknown), (unknown), Vincent Boudy	14
16	Methodologies for assessing the acceptability of oral formulations among children and older adults: a systematic review 2018 ·Drug Discovery Today ·Sejal R. Ranmal, (unknown), Felipe L. Lopez, Fabrice Ruiz, Mine Orlu, Catherine Tuleu, Jennifer Walsh, Fang Liu	50
17	Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort 2018 ·Journal of Neurology Neurosurgery & Psychiatry ·(unknown), Romain Olekhnovitch, Fabrice Ruiz, Claudine Berr, Bernard Bégaud, Marcel Goldberg, Marie Zins, Thibault Mura	23
18	High quality standards for a large-scale prospective population-based observational cohort: Constances 2016 ·BMC Public Health ·Fabrice Ruiz, Marcel Goldberg, (unknown), Anna Ozguler, (unknown), (unknown), Violaine Giraud, T. Pérez, Nicolás Roche, Marie Zins	51
19	Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation 2012 ·Journal of Antimicrobial Chemotherapy ·Raoul Herbrecht, Denis Caillot, Catherine Cordonnier, Anne Auvrignon, Anne Thiébaut, Benoît Brethon, Mauricette Michallet, Nizar Mahlaoui, (unknown), P Preziosi, Fabrice Ruiz, Norbert Claude Gorin, Jean‐Pierre Gangneux	37
20	Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid‐based cytology in primary cervical cancer screening: The FASE study 2010 ·International Journal of Cancer ·Joseph Monsonégo, Michael G. Hudgens, Laurent Zerat, (unknown), Karí Syrjänen, Philippe Halfon, Fabrice Ruiz, Jennifer S. Smith	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact